$130.2 M

EKSO Mkt cap, 15-Oct-2018

$5.5 M

Ekso Bionics Revenue Q2, 2018
Ekso Bionics Gross profit (Q2, 2018)1.7 M
Ekso Bionics Gross profit margin (Q2, 2018), %31.6%
Ekso Bionics Net income (Q2, 2018)-15.9 M
Ekso Bionics EBIT (Q2, 2018)-15.8 M
Ekso Bionics Cash, 30-Jun-201813.9 M

Ekso Bionics Revenue

Ekso Bionics revenue was $7.35 m in FY, 2017

Embed Graph

Ekso Bionics Income Statement

Annual

USDFY, 2016FY, 2017

Revenue

14.2m7.4m

Cost of goods sold

11.3m5.3m

Gross profit

2.9m2.1m

Gross profit Margin, %

21%28%

Sales and marketing expense

11.0m13.2m

R&D expense

8.9m9.5m

General and administrative expense

10.9m10.7m

Operating expense total

30.7m33.7m

EBIT

(27.6m)(31.6m)

EBIT margin, %

(194%)(430%)

Interest expense

16.0k648.0k

Interest income

12.0k

Net Income

(23.5m)(29.1m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Revenue

1.2m1.6m1.7m2.1m2.9m8.5m1.6m1.6m1.4m2.5m5.5m

Cost of goods sold

1.2m1.1m1.3m1.6m2.4m7.0m1.3m1.2m1.1m1.8m3.8m

Gross profit

45.6k479.8k403.0k502.0k468.0k1.5m203.0k403.0k352.0k767.0k1.7m

Gross profit Margin, %

4%30%24%24%16%18%13%25%25%30%32%

Sales and marketing expense

1.8m1.6m1.9m2.5m2.4m2.5m2.9m2.7m3.1m3.9m7.8m

R&D expense

698.9k1.1m983.0k1.7m1.7m2.1m2.2m2.2m2.9m1.8m3.2m

General and administrative expense

1.8m1.5m1.7m1.9m1.6m3.5m2.5m2.3m2.6m3.7m6.6m

Operating expense total

4.4m4.2m4.5m6.1m5.6m8.1m7.6m7.3m8.5m9.4m17.5m

EBIT

(4.3m)(3.7m)(4.1m)(5.6m)(5.2m)(6.6m)(7.4m)(6.9m)(8.1m)(8.6m)(15.8m)

EBIT margin, %

(360%)(235%)(242%)(267%)(178%)(78%)(477%)(430%)(567%)(342%)(288%)

Interest expense

3.8k2.4k3.0k3.0k4.0k163.0k324.0k

Interest income

1.5k1.0k4.0k3.0k2.0k

Net Income

56.1m12.0m(4.1m)(5.6m)(5.2m)(3.7m)(5.8m)(8.5m)(8.3m)(7.9m)(15.9m)

Ekso Bionics Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

25.2m19.6m16.8m27.8m

Accounts Receivable

Inventories

388.0k436.0k1.6m3.0m

Current Assets

29.3m25.2m20.7m34.9m

PP&E

2.1m2.6m2.4m2.2m

Goodwill

189.0k189.0k189.0k

Total Assets

33.5m32.2m24.4m38.0m

Accounts Payable

783.0k2.7m1.9m2.4m

Short-term debt

Current Liabilities

6.6m8.6m6.3m9.2m

Long-term debt

Total Liabilities

17.9m16.6m

Additional Paid-in Capital

94.5m100.1m121.3m165.8m

Retained Earnings

(71.8m)(91.4m)(114.9m)(144.2m)

Total Equity

22.8m8.8m6.5m21.4m

Financial Leverage

1.5 x3.7 x3.7 x1.8 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Cash

11.0m7.2m21.1m16.3m11.2m12.3m4.7m12.8m9.4m20.6m13.9m

Accounts Receivable

1.5m1.9m1.5m2.4m2.2m2.4m1.6m2.2m1.3m

Inventories

1.3m864.4k838.0k1.2m1.2m2.5m2.4m1.9m1.8m2.8m2.4m

Current Assets

15.3m11.7m25.6m22.2m17.2m18.2m9.4m17.6m13.3m27.9m20.4m

PP&E

1.8m2.0m2.2m2.2m2.4m2.6m2.6m2.6m2.5m2.4m2.3m

Goodwill

189.0k189.0k189.0k189.0k189.0k189.0k

Total Assets

18.6m15.4m30.0m26.9m22.1m22.6m13.6m21.6m16.9m31.0m23.2m

Accounts Payable

1.2m1.1m1.5m2.3m2.1m3.6m2.1m1.4m2.9m3.4m2.6m

Current Liabilities

6.1m5.9m6.7m8.4m8.3m7.8m5.8m5.5m7.0m10.0m9.4m

Total Liabilities

16.1m15.6m

Additional Paid-in Capital

45.5m45.6m94.9m95.4m95.9m101.7m102.3m117.5m121.9m167.4m167.8m

Retained Earnings

(63.7m)(51.6m)(75.9m)(81.6m)(86.7m)(95.0m)(100.8m)(109.3m)(123.3m)(152.1m)(160.0m)

Total Equity

(18.1m)(5.9m)19.1m13.9m9.2m6.8m1.6m8.2m(1.4m)14.8m7.6m

Financial Leverage

-1 x-2.6 x1.6 x1.9 x2.4 x3.3 x8.7 x2.6 x-12.2 x2.1 x3 x

Ekso Bionics Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(33.8m)(19.6m)(23.5m)(29.1m)

Depreciation and Amortization

745.0k933.0k1.9m1.7m

Accounts Receivable

(1.0m)(520.0k)154.0k(1.1m)

Inventories

354.0k(200.0k)(541.0k)(2.1m)

Accounts Payable

(716.0k)1.7m(818.0k)77.0k

Cash From Operating Activities

(15.0m)(18.3m)(25.0m)(31.2m)

Cash From Investing Activities

(1.5m)(1.5m)(1.1m)(456.0k)

Short-term Borrowings

(2.6m)(60.0k)(79.0k)

Long-term Borrowings

(54.0k)

Cash From Financing Activities

40.9m14.1m23.3m42.6m

Interest Paid

138.0k12.0k16.0k429.0k

Income Taxes Paid

38.0k5.0k33.0k20.0k

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

56.1m12.0m(4.1m)(5.6m)(5.2m)(3.7m)(5.8m)(8.5m)(8.3m)(7.9m)(15.9m)

Depreciation and Amortization

428.0k888.0k

Accounts Receivable

1.5m1.9m1.5m2.4m2.2m2.4m1.6m2.2m1.3m(798.0k)(678.0k)

Inventories

(286.0k)(198.0k)

Accounts Payable

1.2m1.1m1.5m2.3m2.1m3.6m2.1m1.4m2.9m1.0m210.0k

Cash From Operating Activities

(6.7m)(12.8m)

Purchases of PP&E

(31.0k)(31.0k)

Cash From Investing Activities

(31.0k)(31.0k)

Cash From Financing Activities

(399.0k)(994.0k)

Interest Paid

238.0k

Ekso Bionics Ratios

USDY, 2018

Financial Leverage

3 x
Report incorrect company information